The Patient Signal

In this episode, we explore the FDA's new guidance exempting certain wellness features and clinical decision support tools from medical device oversight, fostering innovation in wearables and software. We also delve into the role of AI in pharmaceutical customer relations, highlighting the need for seamless integration to enhance sales and support. Eli Lilly's acquisition of Ventyx Biosciences marks a significant expansion in immunology, while the biopharma industry sees a strategic focus on metabolic medicines despite fewer partnerships. Color Health's collaboration with Evry Health aims to integrate cancer care into employer health plans, and PwC calls for a reinvention in biopharma to stay competitive. Adam Feuerstein reports on the biotech industry's maturation, and Sam Ash emphasizes careful AI implementation in healthcare. Tensive Srl's bioabsorbable breast implant shows promising trial results, and Boltz PBC launches to democratize AI in drug discovery. Parabilis Medicines secures funding for desmoid tumor treatments, and venture capital in healthcare increasingly focuses on AI integration. Finally, collaborations like Anthropic with Genmab and Hippocratic AI with Boston Consulting Group highlight AI's growing role in healthcare innovation, while AI's impact on oral surgery diagnostics is explored in the British Dental Journal.

Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture.

As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics.

Start your VoiceStream free trial today!